Atossa Therapeutics, Inc. Share Price & Technical Analysis
ATOS · $2.58 (-41.36%)
Healthcare / Biotechnology
$2.58
-41.36%
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as we…
Price chart
Seasonality
Jun has 3 positive and 2 negative years (last 5 years shown)
-14% return in Jun, 12% avg return in past 3 year Jun month.
-35% return in 2026, 30% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -3% | -39% | 23% | 2% | -4% | -14% | – | – | – | – | – | – | -35% |
| 25 | -11% | -3% | -11% | 32% | -15% | 4% | 0% | -8% | 17% | 4% | -13% | -25% | -30% |
| 24 | -5% | 15% | 84% | -18% | -14% | -8% | 12% | 1% | 13% | -8% | -6% | -27% | 39% |
| 23 | 43% | -10% | -1% | -9% | 42% | 40% | -13% | -27% | -7% | -9% | 10% | 21% | 81% |
| 22 | -16% | -12% | -2% | -21% | -3% | 12% | -5% | -3% | -10% | 16% | -24% | -29% | -98% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$38.67M
P/E ratio
—
52W high
$19.35
52W low
$2.52
Volume
4,95,077
Beta
1.15
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Atossa Therapeutics, Inc. share price today?
- Atossa Therapeutics, Inc. (ATOS) last traded around $2.58 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ATOS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ATOS. Download the app for real-time alerts.
- How can I analyze Atossa Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.